Literature DB >> 27168829

Heavy menstrual bleeding and health-associated quality of life in women with von Willebrand's disease.

Igor Govorov1, Lena Ekelund1, Roza Chaireti2, Petra Elfvinge3, Margareta Holmström3, Katarina Bremme1, Miriam Mints1.   

Abstract

Women with the inherited bleeding disorder von Willebrand's disease (VWD) face gender-specific hemostatic challenges during menstruation. Heavy menstrual bleeding (HMB) can negatively affect their overall life activities and the health-associated quality of life. The purpose of the present study was to investigate whether women with VWD experienced HMB and an impaired health-associated quality of life. The study subjects were recruited from the Coagulation Unit of Karolinska University Hospital. Information was retrieved from various self-administered forms and medical records. Of the 30 women (18-52 years) that were included in the present study, 50% suffered from HMB, although the majority received treatment for HMB. In addition, almost all the included women perceived limitations in the overall life activities due to menstruation. The health-associated quality of life for women with HMB was significantly lower (P<0.10) with regards to 'bodily pain' compared with Swedish women of the general population. In conclusion, women with VWD experienced reduced health-associated quality of life as a result of HMB. Therefore, preventing limitations in overall life activities and improving their health-associated quality of life thorough counseling on menstrual bleeding is important for women with VWD.

Entities:  

Keywords:  bleeding disorders; gynecology; heavy menstrual bleeding; hematology; quality of life; von Willebrand's disease

Year:  2016        PMID: 27168829      PMCID: PMC4840542          DOI: 10.3892/etm.2016.3144

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  33 in total

1.  Medical, reproductive and psychosocial experiences of women diagnosed with von Willebrand's disease receiving care in haemophilia treatment centres: a case-control study.

Authors:  A Kirtava; C Drews; C Lally; A Dilley; B Evatt
Journal:  Haemophilia       Date:  2003-05       Impact factor: 4.287

Review 2.  Abnormal uterine bleeding during the reproductive years.

Authors:  Bridget R Davidson; Christina M Dipiero; Kara D Govoni; Susan S Littleton; Jeremy L Neal
Journal:  J Midwifery Womens Health       Date:  2012 May-Jun       Impact factor: 2.388

Review 3.  Disorders of hemostasis and excessive menstrual bleeding: prevalence and clinical impact.

Authors:  Andrea S Lukes; Rezan A Kadir; Flora Peyvandi; Peter A Kouides
Journal:  Fertil Steril       Date:  2005-11       Impact factor: 7.329

4.  Inconsistency of association between type 1 von Willebrand disease phenotype and genotype in families identified in an epidemiological investigation.

Authors:  G Castaman; J C Eikenboom; R M Bertina; F Rodeghiero
Journal:  Thromb Haemost       Date:  1999-09       Impact factor: 5.249

5.  Pictorial blood loss assessment chart in the evaluation of heavy menstrual bleeding: diagnostic accuracy compared to alkaline hematin.

Authors:  Mahmoud S Zakherah; Gamal H Sayed; Sherif A El-Nashar; Mamdouh M Shaaban
Journal:  Gynecol Obstet Invest       Date:  2011-01-13       Impact factor: 2.031

Review 6.  Tranexamic acid: a review of its use in surgery and other indications.

Authors:  C J Dunn; K L Goa
Journal:  Drugs       Date:  1999-06       Impact factor: 9.546

7.  Assessment of patients with menorrhagia: how valid is a structured clinical history as a measure of health status?

Authors:  D A Ruta; A M Garratt; Y C Chadha; G M Flett; M H Hall; I T Russell
Journal:  Qual Life Res       Date:  1995-02       Impact factor: 4.147

8.  Prevalence of von Willebrand disease in children: a multiethnic study.

Authors:  E J Werner; E H Broxson; E L Tucker; D S Giroux; J Shults; T C Abshire
Journal:  J Pediatr       Date:  1993-12       Impact factor: 4.406

9.  Epidemiological investigation of the prevalence of von Willebrand's disease.

Authors:  F Rodeghiero; G Castaman; E Dini
Journal:  Blood       Date:  1987-02       Impact factor: 22.113

10.  Tranexamic acid for the treatment of heavy menstrual bleeding: efficacy and safety.

Authors:  Henri Leminen; Ritva Hurskainen
Journal:  Int J Womens Health       Date:  2012-08-17
View more
  13 in total

Review 1.  Advances in the diagnosis and treatment of Von Willebrand disease.

Authors:  Ruchika Sharma; Veronica H Flood
Journal:  Blood       Date:  2017-11-30       Impact factor: 22.113

Review 2.  Advances in the diagnosis and treatment of Von Willebrand disease.

Authors:  Ruchika Sharma; Veronica H Flood
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

Review 3.  Management of heavy menstrual bleeding on anticoagulation.

Authors:  Bethany Samuelson Bannow
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

4.  Women and girls with haemophilia and bleeding tendencies: Outcomes related to menstruation, pregnancy, surgery and other bleeding episodes from a retrospective chart review.

Authors:  Ateefa Chaudhury; Robert Sidonio; Nisha Jain; Elisa Tsao; Justyna Tymoszczuk; Mariana Oviedo Ovando; Roshni Kulkarni
Journal:  Haemophilia       Date:  2020-12-24       Impact factor: 4.287

5.  Thrombin generation during a regular menstrual cycle in women with von Willebrand disease.

Authors:  Igor Govorov; Katarina Bremme; Tomas L Lindahl; Margareta Holmström; Eduard Komlichenko; Roza Chaireti; Miriam Mints
Journal:  Sci Rep       Date:  2018-11-30       Impact factor: 4.379

6.  Heavy menstrual bleeding on direct factor Xa inhibitors: Rationale and design of the MEDEA study.

Authors:  Eva N Hamulyák; Hanke M G Wiegers; Luuk J J Scheres; Barbara A Hutten; Maria E de Lange; Anne Timmermans; Peter E Westerweel; Marten R Nijziel; Marieke J H A Kruip; Marije Ten Wolde; Paula F Ypma; Frederikus A Klok; Laurens Nieuwenhuizen; Sanne van Wissen; Marcel M C Hovens; Laura M Faber; Pieter W Kamphuisen; Harry R Büller; Saskia Middeldorp
Journal:  Res Pract Thromb Haemost       Date:  2020-12-18

Review 7.  Prophylactic management of patients with von Willebrand disease.

Authors:  Massimo Franchini; Omid Seidizadeh; Pier Mannuccio Mannucci
Journal:  Ther Adv Hematol       Date:  2021-12-22

8.  Gynecologic and obstetric management of women with von Willebrand disease: summary of 3 systematic reviews of the literature.

Authors:  Romina Brignardello-Petersen; Abdallah El Alayli; Nedaa Husainat; Mohamad A Kalot; Shaneela Shahid; Yazan Aljabirii; Alec Britt; Hani Alturkmani; Hussein El-Khechen; Shahrzad Motaghi; John Roller; Rezan Abdul-Kadir; Susie Couper; Peter Kouides; Michelle Lavin; Margareth C Ozelo; Angela Weyand; Paula D James; Nathan T Connell; Veronica H Flood; Reem A Mustafa
Journal:  Blood Adv       Date:  2022-01-11

Review 9.  The lived experience of women with a bleeding disorder: A systematic review.

Authors:  Anna Sanigorska; Steve Chaplin; Mike Holland; Kate Khair; Debra Pollard
Journal:  Res Pract Thromb Haemost       Date:  2022-02-03

10.  The Cost of Von Willebrand Disease in Europe: The CVESS Study.

Authors:  George Morgan; Sarah Brighton; Mike Laffan; Jenny Goudemand; Bethany Franks; Alan Finnegan
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 3.512

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.